Parallel Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $974K | Sell |
|
|||||
|
2025
Q1 | $1.18M | Buy |
|
|||||
|
2024
Q4 | $978K | Sell |
|
|||||
|
2024
Q3 | $1.64M | Buy |
|
|||||
|
2024
Q2 | $1.62M | Buy |
|
|||||
|
2024
Q1 | $1.27M | Buy |
|
|||||
|
2023
Q4 | $964K | Sell |
|
|||||
|
2023
Q3 | $981K | Buy |
|
|||||
|
2023
Q2 | $990K | Buy |
|
|||||
|
2023
Q1 | $930K | Buy |
|
|||||
|
2022
Q4 | $897K | Sell |
|
|||||
|
2022
Q3 | $770K | Buy |
|
|||||
|
2022
Q2 | $757K | Sell |
|
|||||
|
2022
Q1 | $784K | Sell |
|
|||||
|
2021
Q4 | $826K | Buy |
|
|||||
|
2021
Q3 | $838K | Buy |
|
|||||
|
2021
Q2 | $700K | Buy |
|
|||||
|
2021
Q1 | $549K | Sell |
|
|||||
|
2020
Q4 | $583K | Sell |
|
|||||
|
2020
Q3 | $656K | Buy |
|
|||||
|
2020
Q2 | $623K | Sell |
|
|||||
|
2020
Q1 | $537K | Buy |
|
|||||
|
2019
Q4 | $558K | Sell |
|
|||||
|
2019
Q3 | $519K | Buy |
|
|||||
|
2019
Q2 | $434K | Sell |
|
|||||
|
2019
Q1 | $469K | Buy |
|
|||||
|
2018
Q4 | $421K | Buy |
|
|||||
|
2018
Q3 | $404K | Sell |
|
|||||
|
2018
Q2 | $360K | Buy |
|
|||||
|
2018
Q1 | $358K | Buy |
|
|||||
|
2017
Q4 | $321K | Sell |
|
|||||
|
2017
Q3 | $313K | Buy |
|
|||||
|
2017
Q2 | $211K | Buy |
|
|||||
|
2017
Q1 | $138K | Buy |
|
|||||
|
2016
Q4 | $97K | Buy |
|